| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.00B | +15.7% | +31.1% |
| Cost of Revenue | $974.0M | +42.2% | +57.3% |
| Gross Profit | $2.03B | +6.2% | +21.5% |
| R&D Expense | $734.0M | +43.6% | +48.4% |
| SG&A Expense | $316.0M | +77.5% | +92.8% |
| Operating Income | -$183.0M | -146.1% | -183.6% |
| Pre-tax Income | -$156.0M |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.36B | -43.1% | -0.8% |
| Short-term Investments | $747.0M | +97.6% | -18.5% |
| Accounts Receivable | $2.85B | +34.8% | +46.3% |
| Current Assets | $7.71B | -7.8% | +11.8% |
| Total Assets | $46.27B | +85.2% | +110.3% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.20B | — | — |
| Investing Cash Flow | -$2.10B | — | — |
| Financing Cash Flow | -$1.00B | — | — |
| -128.4% |
| -150.2% |
| Income Tax | $21.0M | -82.1% | -56.6% |
| Net Income | -$177.0M | -141.0% | -167.5% |
| EPS (Basic) | -$0.22 | -136.1% | -156.4% |
| EPS (Diluted) | -$0.22 | -136.1% | -159.5% |
| $9.01B |
| +12.4% |
| +16.9% |
| Total Liabilities | $18.60B | +19.3% | +25.9% |
| Stockholders' Equity | $27.67B | +194.6% | +282.7% |